Valeant Pharma (VRX) volatility spikes after Left said to take new short

Valeant Pharma (NYSE: VRX) July call option implied volatility is at 123, compared to closing level of 82 last night, August is at 94, compared to a closing level of 86, after Citron's Andrew Left said to take a new short stake and says worth $0.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1.2 calls to 1 put into quarter results
• SPS Commerce (SPSC) 400 contracts of July 60 calls trade
• Quantum Computing Inc (QUBT) call put ratio 6.5 calls to 1 put with a focus on June 26 weekly 12.50 calls as share price up 3.1%